Key facts
- This page summarizes Daniel E. Geffken's Form 4 filing for WINDTREE THERAPEUTICS INC /DE/ (WINT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Aug 2023, 16:37.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date.
Footnote F2
Adjusted to reflect 1-for-50 reverse stock split effective February 24, 2023.
Footnote F3
The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date.